LYTIR

Company · VCYT

Veracyte, Inc.

Name as listed on its exchange; filed with the SEC as VERACYTE, INC.

Nasdaq's symbol directory lists VCYT on Nasdaq as “Veracyte, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 11 occasions ($3.1M); 5 planned-sale notices; 2 filings by holders of 5% or more; 2 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $3.1M in total.Jun: Insider sales $197KSep: Insider sales $1.7MOct: Insider sales $1.2MDecJanFebMarAprMayJunJulAugSepOctNov$1.7M
Insider purchases above the line: $0Insider sales below: $3.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. EASTHAM KARIN sold on 2 days all under a 10b5-1 plan latest Oct 27, 2026 sold $940K
  2. Holstein Jens sold on 3 days all under a 10b5-1 plan latest Oct 27, 2026 sold $932K
  3. Febbo Phillip G., Chief Scientific & Med Officer sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $564K
  4. Bhanji Muna sold on 2 days all under a 10b5-1 plan latest Oct 19, 2026 sold $162K
  5. Leite John, Global Chief Commercial Off sold on 1 day all under a 10b5-1 plan latest Sep 21, 2026 sold $161K
  6. Chambers Rebecca, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $157K
  7. McGuire Annie, EVP, General Counsel sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $140K
Every trade (11)
  1. SELLEASTHAM KARIN sold Oct 27, 2026 14,850 shares 10b5-1 plan (scheduled) filing $743K
  2. SELLHolstein Jens sold Oct 27, 2026 7,500 shares 10b5-1 plan (scheduled) filing $375K
  3. SELLBhanji Muna sold Oct 19, 2026 1,864 shares 10b5-1 plan (scheduled) filing $81K
  4. SELLHolstein Jens sold Sep 24, 2026 7,500 shares 10b5-1 plan (scheduled) filing $352K
  5. SELLLeite John, Global Chief Commercial Off sold Sep 21, 2026 4,015 shares 10b5-1 plan (scheduled) filing $161K
  6. SELLHolstein Jens sold Sep 14, 2026 5,000 shares 10b5-1 plan (scheduled) filing $205K
  7. SELLFebbo Phillip G., Chief Scientific & Med Officer sold Sep 4, 2026 13,110 shares 2 legs combined 10b5-1 plan (scheduled) filing $564K
  8. SELLChambers Rebecca, Chief Financial Officer sold Sep 4, 2026 3,652 shares 2 legs combined 10b5-1 plan (scheduled) filing $157K
  9. SELLMcGuire Annie, EVP, General Counsel sold Sep 4, 2026 3,254 shares 2 legs combined 10b5-1 plan (scheduled) filing $140K
  10. SELLBhanji Muna sold Sep 1, 2026 1,864 shares 10b5-1 plan (scheduled) filing $80K
  11. SELLEASTHAM KARIN sold Jun 18, 2026 3,729 shares 2 legs combined 10b5-1 plan (scheduled) filing $197K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. KARIN EASTHAM filed Oct 27, 2026 Director 14,850 shares planned sale date 10/27/2026 filing $716K
  2. JENS HOLSTEIN filed Oct 27, 2026 Director 7,500 shares planned sale date 10/27/2026 filing $375K
  3. JENS HOLSTEIN filed Sep 24, 2026 Director 7,500 shares planned sale date 09/24/2026 filing $352K
  4. JOHN LEITE filed Sep 21, 2026 Officer 4,015 shares planned sale date 09/21/2026 filing $160K
  5. JENS HOLSTEIN filed Sep 14, 2026 Director 5,000 shares planned sale date 09/14/2026 filing $205K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Artisan Partners Asset Management Inc. filed Nov 12, 2026 Schedule 13G/A passive 2,312,149 shares filing 2.9%
  2. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 6,172,996 shares filing 7.7%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Feb 18, 2026 reported Mar 9, 2026 one of 85 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Other events filing Nov 4, 2026
  2. Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Regulation FD disclosure filing Sep 14, 2026

Federal contracts · USAspending.gov

Federal contracts

7 contract awards first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $1.3M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.

  1. Department of Veterans Affairs Dec 31, 2025 to VERACYTE, INC. award $716K
  2. Department of Veterans Affairs Jan 8, 2026 to VERACYTE LABS SD CORPORATION award $345K
  3. Department of Veterans Affairs Oct 1, 2026 to VERACYTE, INC. award $68K
  4. Department of Veterans Affairs Jul 9, 2026 to VERACYTE, INC. award $50K
  5. Department of Veterans Affairs Jul 28, 2026 to VERACYTE, INC. award $50K
  6. Department of Veterans Affairs Jun 10, 2026 to VERACYTE LABS SD CORPORATION award $16K
  7. Department of Veterans Affairs Oct 1, 2026 to VERACYTE, INC. award $13K

Sources: SEC EDGAR (Forms 4, 144 and 8-K), USAspending.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.